{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:23:03Z","timestamp":1782400983978,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.vaccine.2021.11.003","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T20:40:45Z","timestamp":1638304845000},"page":"7661-7668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-2825","authenticated-orcid":false,"given":"Jaqueline","family":"Matias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyne","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6248-4985","authenticated-orcid":false,"given":"Andaleeb","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0396-8757","authenticated-orcid":false,"given":"Sukanya","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-6205","authenticated-orcid":false,"given":"Gunjan","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husrev","family":"Diktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey E.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"DePonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-6242","authenticated-orcid":false,"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5589-9450","authenticated-orcid":false,"given":"Jesus G.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-6510","authenticated-orcid":false,"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-6047","authenticated-orcid":false,"given":"Erol","family":"Fikrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.11.003_b0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1006241108739","article-title":"Ticks feeding on humans: a review of records on human-biting Ixodoidea with special reference to pathogen transmission","volume":"23","author":"Estrada-Pena","year":"1999","journal-title":"Exp Appl Acarol"},{"issue":"S1","key":"10.1016\/j.vaccine.2021.11.003_b0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/S0031182004005967","article-title":"The global importance of ticks","volume":"129","author":"Jongejan","year":"2004","journal-title":"Parasitology"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.003_b0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41579-020-0400-5","article-title":"Interactions between Borrelia burgdorferi and ticks","volume":"18","author":"Kurokawa","year":"2020","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.003_b0020","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1128\/IAI.68.4.2183-2186.2000","article-title":"Acquisition of coinfection and simultaneous transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis ticks","volume":"68","author":"Burns","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.003_b0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-4894(90)90085-Q","article-title":"Borrelia burgdorferi and Babesia microti: efficiency of transmission from reservoirs to vector ticks (Ixodes dammini)","volume":"70","author":"Mather","year":"1990","journal-title":"Exp Parasitol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.11.003_b0030","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1073\/pnas.93.12.6209","article-title":"Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle","volume":"93","author":"Telford","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.11.003_b0035","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/brv.12384","article-title":"Tick attachment cement\u2013reviewing the mysteries of a biological skin plug system","volume":"93","author":"Suppan","year":"2018","journal-title":"Biol Rev"},{"issue":"36","key":"10.1016\/j.vaccine.2021.11.003_b0040","doi-asserted-by":"crossref","first-page":"26298","DOI":"10.1074\/jbc.M513010200","article-title":"Antiinflammatory and immunosuppressive activity of sialostatin L, a salivary cystatin from the tick Ixodes scapularis","volume":"281","author":"Kotsyfakis","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2021.11.003_b0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.161.2.332","article-title":"Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick","volume":"161","author":"Ribeiro","year":"1985","journal-title":"Ixodes dammini J Exp Med"},{"key":"10.1016\/j.vaccine.2021.11.003_b0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fcimb.2017.00281","article-title":"The essential role of tick salivary glands and saliva in tick feeding and pathogen transmission","volume":"7","author":"Simo","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2021.11.003_b0055","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3389\/fimmu.2017.01784","article-title":"Ticks, ixodes scapularis, feed repeatedly on white-footed mice despite strong inflammatory response: an expanding paradigm for understanding tick-host interactions","volume":"8","author":"Anderson","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.003_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2741\/4590","article-title":"Tick-host-pathogen systems immunobiology: an interactive trio","volume":"23","author":"Wikel","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.003_b0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2307\/3272160","article-title":"Acquired immunity to ticks","volume":"25","author":"Trager","year":"1939","journal-title":"J Parasitol"},{"issue":"3-4","key":"10.1016\/j.vaccine.2021.11.003_b0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0304-4017(84)90099-2","article-title":"Immunomodulation of host responses to ectoparasite infestation\u2013an overview","volume":"14","author":"Wikel","year":"1984","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2021.11.003_b0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fcimb.2017.00506","article-title":"Cattle tick rhipicephalus microplus-host interface: a review of resistant and susceptible host responses","volume":"7","author":"Tabor","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.003_b0080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2307\/3283729","article-title":"Acquired resistance of guinea pigs to dermacentor andersoni mediated by humoral factors","volume":"79","author":"Whelen","year":"1993","journal-title":"J Parasitol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.003_b0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF00048814","article-title":"Acquired resistance in dogs to repeated infestation with Ixodes scapularis (Acari: Ixodidae) reduces tick viability and reproductive success","volume":"19","author":"Gebbia","year":"1995","journal-title":"Exp Appl Acarol"},{"key":"10.1016\/j.vaccine.2021.11.003_b0090","doi-asserted-by":"crossref","unstructured":"Nazario S, Das S, de Silva AM, Deponte K, Marcantonio N, Anderson JF, et al. Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity. Am J Trop Med Hyg. 1998;58:780-5.","DOI":"10.4269\/ajtmh.1998.58.780"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.003_b0095","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1371\/journal.pone.0000451","article-title":"Immunity against Ixodes scapularis salivary proteins expressed within 24 hours of attachment thwarts tick feeding and impairs Borrelia transmission","volume":"2","author":"Narasimhan","year":"2007","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.003_b0100","doi-asserted-by":"crossref","first-page":"101369","DOI":"10.1016\/j.ttbdis.2019.101369","article-title":"Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistance","volume":"11","author":"Narasimhan","year":"2020","journal-title":"Ticks Tick Borne Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.003_b0105","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1073\/pnas.0307669100","article-title":"Disruption of Ixodes scapularis anticoagulation by using RNA interference","volume":"101","author":"Narasimhan","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.003_b0110","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.003_b0115","doi-asserted-by":"crossref","first-page":"101529","DOI":"10.1016\/j.ttbdis.2020.101529","article-title":"Repeat tick exposure elicits distinct immune responses in guinea pigs and mice","volume":"11","author":"Kurokawa","year":"2020","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.003_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.en.41.010196.000245","article-title":"Host immunity to ticks","volume":"41","author":"Wikel","year":"1996","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.vaccine.2021.11.003_b0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4269\/ajtmh.20-0776","article-title":"Naturally acquired resistance to ixodes scapularis elicits partial immunity against other tick vectors in a laboratory host","volume":"104","author":"Lynn","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"7644","key":"10.1016\/j.vaccine.2021.11.003_b0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.11.003_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"234","key":"10.1016\/j.vaccine.2021.11.003_b0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008222","article-title":"Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis","volume":"6","author":"Das","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2021.11.003_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj9827","article-title":"mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent","volume":"13","author":"Sajid","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2021.11.003_b0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3201\/eid1101.040303","article-title":"Hypersensitivity to ticks and Lyme disease risk","volume":"11","author":"Burke","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.003_b0155","doi-asserted-by":"crossref","first-page":"100865","DOI":"10.1016\/j.jbc.2021.100865","article-title":"Molecular basis of anticoagulant and anticomplement activity of the tick salivary protein Salp14 and its homologs","volume":"297","author":"Denisov","year":"2021","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.003_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1081-1206(10)63082-7","article-title":"Unusual manifestations of hypersensitivity after a tick bite: report of two cases","volume":"79","author":"Beaudouin","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2021.11.003_b0165","doi-asserted-by":"crossref","unstructured":"Schwartz BS, Ribeiro JM, Goldstein MD. Anti-tick antibodies: an epidemiologic tool in Lyme disease research. Am J Epidemiol 1990;132:58-66.","DOI":"10.1093\/oxfordjournals.aje.a115643"},{"issue":"12","key":"10.1016\/j.vaccine.2021.11.003_b0170","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.2105\/AJPH.83.12.1746","article-title":"Antibodies to Borrelia burgdorferi and tick salivary gland proteins in New Jersey outdoor workers","volume":"83","author":"Schwartz","year":"1993","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.003_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/153036602760260724","article-title":"Investigations on the mode and dynamics of transmission and infectivity of Borrelia burgdorferi sensu stricto and Borrelia afzelii in Ixodes ricinus ticks","volume":"2","author":"Crippa","year":"2002","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.003_b0180","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/infdis\/167.5.1082","article-title":"Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks","volume":"167","author":"Piesman","year":"1993","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.003_b0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/jcm.25.3.557-558.1987","article-title":"Duration of tick attachment and Borrelia burgdorferi transmission","volume":"25","author":"Piesman","year":"1987","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.003_b0190","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2021.11.003_b0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersdorfer","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.003_b0200","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2021.11.003_b0205","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.003_b0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.vaccine.2005.07.085","article-title":"From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library","volume":"24","author":"Oliveira","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.003_b0215","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(02)00325-4","article-title":"Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation","volume":"16","author":"Anguita","year":"2002","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.003_b0220","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ttbdis.2019.06.002","article-title":"Borrelia burgdorferi chemotaxis toward tick protein Salp12 contributes to acquisition","volume":"10","author":"Murfin","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.vaccine.2021.11.003_b0225","doi-asserted-by":"crossref","unstructured":"Baeten LA, Podell BK, Sluder AE, Garritsen A, Bowen RA, Poznansky MC. Standardized guinea pig model for Q fever vaccine reactogenicity. PLoS One. 2018;13:e0205882.","DOI":"10.1371\/journal.pone.0205882"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21014365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21014365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:05:32Z","timestamp":1759403132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21014365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":45,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0264410X21014365"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}